Get started
Author

Aleksandra Gamrat-Żmuda

Observed name: A Gamrat-Żmuda
OpenAlex ID: A5117487166
Liver impairment and medical management of Cushing syndrome and MACS
2025 · Mari Minasyan, Wiktoria Suchy, et al. · Frontiers in Endocrinology · 8
PDF
Ectopic Cushing’s Syndrome in Advanced Small-Cell Lung Cancer (SCLC): Clinical Challenges and Therapeutic Insights
2025 · Aleksandra Gamrat-Żmuda, Mari Minasyan, et al. · Cancers · 8
PDF
Cushing syndrome of different etiologies - cardiometabolic complications, venous thromboembolic events and mortality: data from ERCUSYN Krakow database
2026 · Mari Minasyan, Aleksandra Gamrat-Żmuda, et al. · Frontiers in Endocrinology · 2
PDF
NE13 Neuropsychiatric disturbances in patients with Cushing’s syndrome are highly prevalent and may represent the initial manifestation of the disease: The ERCUSYN Krakow Database
2026 · M Borysowicz, M Minasyan, et al. · European Journal of Endocrinology · 1
PDF
Individualized osilodrostat treatment for patients with ACTH-dependent Cushing’s syndrome: real-world evidence
2026 · Aleksandra Gilis-Januszewska, Aleksandra Gamrat-Żmuda, et al. · Frontiers in Endocrinology · 1
PDF
The Differences Between Dopamine Agonist-Resistant and -Non-Resistant Prolactinomas: Are There Any Predictors of a Good Response?
2026 · Maria Komisarz-Calik, Anna Bogusławska, et al. · Biomedicines · 1
PDF
Serum inflammation based scores in prediction of liver fibrosis among cushing syndrome and MACS patients: data from ERCUSYN krakow database
2025 · Wiktoria Suchy, Mari Minasyan, et al. · Endocrine Abstracts · 1
Presentation, management, and outcomes of ectopic Cushing syndrome: an international, multicentre, retrospective, cohort study
2026 · Shireen R Chacko, Anina F Peersen, et al. · The Lancet Diabetes & Endocrinology
Case Report: Long-lasting adrenal insufficiency following successful osilodrostat therapy with subsequent recurrence of Cushing’s syndrome
2026 · Wiktoria Suchy, Ewelina Rzepka, et al. · Frontiers in Endocrinology
PDF
ER07 Hypokalemia persists across the spectrum of ectopic Cushing’s syndrome despite marked etiology-specific phenotypic differences
2026 · A Gamrat-Żmuda, M Minasyan, et al. · European Journal of Endocrinology
PDF
CB06 High burden of osteoporosis and fragility fractures in Cushing’s syndrome: a call for active screening
2026 · M Minasyan, K Majka, et al. · European Journal of Endocrinology
PDF
NE04 Sex-related and age-related differences in patients with prolactinoma – a retrospective single-center study
2026 · M Komisarz-Calik, A Bogusławska, et al. · European Journal of Endocrinology
PDF
EP932 - ECE_3520 - Initial clinical presentation differs substantially between ectopic Cushing's syndrome and Cushing's disease and could be the reason for the diagnostic delay. ERCUSYN Krakow database
2026 · Aleksandra Gamrat-Żmuda, Mari Minasyan, et al. · European Journal of Endocrinology
EP1814 - LBA_ECE_1433 - Multimodal management of silent corticotroph tumors with Crooke's cell features transforming into severe Cushing's disease—the ERCUSYN Kraków cohort
2026 · Aleksandra Gilis-Januszewska, Aleksandra Gamrat-Żmuda, et al. · European Journal of Endocrinology
PDF
EP114 - ECE_3413 - Is mild autonomous cortisol secretion (MACS) truly mild?
2026 · Mari Minasyan, Aleksandra Gamrat-Żmuda, et al. · European Journal of Endocrinology
PDF
EP1083 - ECE_3451 - Management of Cushing syndrome of different etiologies—a single center real life experience: data from ERCUSYN Krakow database
2026 · Mari Minasyan, Aleksandra Gamrat-Żmuda, et al. · European Journal of Endocrinology
PDF
P246 - ECE_3578 - Osilodrostat in a block-and-replace strategy for successful management of cycling Cushing’s syndrome—case series
2026 · Wiktoria Suchy, Mari Minasyan, et al. · European Journal of Endocrinology
EP1093 - ECE_3508 - Are the patients with prolactinomas truly resistant to dopamine agonists or treated with too low doses?– single-center observational study
2026 · Maria Aleksandra Komisarz-Calik, Anna Bogusławska, et al. · European Journal of Endocrinology
PDF
P247 - ECE_3541 - Block-and-replace therapy with osilodrostat in Cushing’s syndrome: a real-life single-center experience
2026 · Aleksandra Gilis-Januszewska, Aleksandra Gamrat-Żmuda, et al. · European Journal of Endocrinology
PDF
Case Report: Continuous block-and-replace strategy with osilodrostat in a patient with cyclic Cushing’s syndrome
2026 · Wiktoria Suchy, Mari Minasyan, et al. · Frontiers in Endocrinology
PDF
OC42 - Ectopic Cushing's syndrome (ECS) - a diagnostic challenge. Differences between ECS and Cushing's disease (CD) - European Cushing's syndrome registry, ERCUSYN, Kraków
2025 · A Gamrat-Żmuda, M Minasyan, et al. · European Journal of Endocrinology
PDF
P03 - Liver assessment in the shear wave elastography in patients with Cushing syndrome and MACS: Data from ERCUSYN Krakow database
2025 · M Minasyan, A Fedak, et al. · European Journal of Endocrinology
PDF
Persistent severe hypokalemia as a critical marker of diagnosis and response to treatment in ectopic cushing's syndrome (ECS) caused by small-cell lung cancer (SCLC)
2025 · Aleksandra Gamrat-Żmuda, Mari Minasyan, et al. · Endocrine Abstracts
Osilodrostat effectiveness in the treatment of cushing's disease (CD) and ectopic cushing's syndrome (ECS)- a single-center real-life experience
2025 · Aleksandra Gamrat-Żmuda, Martyna Więcławek, et al. · Endocrine Abstracts
Works count: 24
Citation count: 22
H-index: 2
I10-index:
Year
Topic
Type